Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005; 61: 675-681)

Mark Naunton, Michiel Duyvendak, Gregory M. Peterson, Jacobus R J B Brouwers

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)


The results from the recent study by Glintborg et al. [1] are not surprising (lack of significant drug-drug interactions in patients recently discharged from hospital). It is expected that clinically important interactions are identified while the patient is in hospital, with one of the offending agents stopped or changed to a safer alternative before discharge. Furthermore, any clinically important interactions are likely to be identified by the patient’s community pharmacist, who alerts the general practitioner and prevents possible harm before the prescription is even dispensed.
Original languageEnglish
Pages (from-to)159-160
Number of pages2
JournalEuropean Journal of Clinical Pharmacology
Issue number2
Publication statusPublished - 1 Feb 2006
Externally publishedYes


Dive into the research topics of 'Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005; 61: 675-681)'. Together they form a unique fingerprint.

Cite this